Preview
Ever since Heberden's classic description of angina pectoris almost 200 years ago, most clinicians have devoted a major part of their practice to the assessment and management of patients either known to have coronary artery disease (CAD) or at high risk for its development. In this article, Dr Lavie and his colleagues discuss the importance of reducing risks for CAD and the factors to consider when deciding which screening tests to use in assessing patients with known or suspected CAD.